LifeCell Corp (NASDAQ:LIFC.DL)

CAPS Rating: No stars

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

Featured Broker Partners


Advertisement